Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review Publisher

Gholammostafaei FS¹ ; Didari T² ; Ramandi M³ ; Vafaee R⁴ ; Rostaminejad M¹

Source: Gastroenterology and Hepatology from Bed to Bench Published:2021

Abstract

Celiac disease (CD) is an autoimmune disorder of the gastrointestinal tract in a genetically susceptible person. Gluten is the most crucial trigger factor for CD, and environmental factors such as microbiota and opportunistic infection risk its pathogenesis. Coronavirus disease 19 (COVID-19) spread rapidly and became a problem for healthcare systems worldwide. Little is known about the risk of severe COVID-19 and the role of dysbiosis among patients with CD. There is also a lack of knowledge about the effects of CD gut microbiota on COVID-19 infection. Therefore, the current review discusses the relationship between CD and risk factors such as microbiota for susceptibility to COVID-19. ©2021 RIGLD, Research Institute for Gastroenterology and Liver Diseases

Related Docs

View other Related Docs

1. The Possible Role of Pathogenic and Non-Pathogenic Bacteria in Initiation and Exacerbation of Celiac Disease; a Comprehensive Review, Current Pharmaceutical Biotechnology (2020)

2. The Role of Mucosal Immunity and Recombinant Probiotics in Sars-Cov2 Vaccine Development, Probiotics and Antimicrobial Proteins (2021)

3. The Effects of Probiotics on Gastrointestinal Symptoms and Microbiota in Patients With Celiac Disease: A Systematic Review and Meta-Analysis on Clinical Trials, Clinical and Experimental Medicine (2023)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (4)

Hossein Khalili (1)

Other Related Docs

4. Celiac Disease: A Review From Genetic to Treatment, Iranian Biomedical Journal (2024)

5. Are Viruses and Parasites Linked to Celiac Disease? a Question That Still Has No Definite Answer, Current Pharmaceutical Biotechnology (2019)

6. Gut Microbiota Might Act As a Potential Therapeutic Pathway in Covid-19, Current Pharmaceutical Biotechnology (2022)

7. The Association Between Dietary Intakes of Zinc, Vitamin C and Covid-19 Severity and Related Symptoms: A Cross-Sectional Study, Clinical Nutrition ESPEN (2023)

8. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

9. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)

10. Clinical Manifestations of Covid-19, Advances in Experimental Medicine and Biology (2021)

11. Prevalence and Outcome of Covid-19 Among Iranian Celiac Patients, Gastroenterology and Hepatology from Bed to Bench (2022)

12. Geriatrics and Covid-19, Advances in Experimental Medicine and Biology (2021)

13. Geriatric Challenges in the New Coronavirus Disease-19 (Covid-19) Pandemic: A Systematic Review, Medical Journal of the Islamic Republic of Iran (2020)

14. Human Coronaviruses Sars-Cov, Mers-Cov, and Sars-Cov-2 in Children, Journal of Pediatric Nursing (2021)

15. Prevalence of Celiac Disease in Children Under-18 Years Old With Diabetes Mellitus Type I, Tehran University Medical Journal (2019)

16. The Emerging Role of Probiotics As a Mitigation Strategy Against Coronavirus Disease 2019 (Covid-19), Archives of Virology (2021)

17. Factors Associated With Covid-19 Morbidity and Mortality: A Narrative Review, Journal of Iranian Medical Council (2020)

18. Coronavirus Disease 2019 (Covid-19) in Pediatric Patients With Autoimmune Disorders, European Journal of Pediatrics (2023)

19. Accuracy of Chest Computed Tomography and Reverse Transcription Polymerase Chain Reaction in Diagnosis of 2019 Novel Coronavirus Disease; a Systematic Review and Meta-Analysis, Immunopathologia Persa (2021)

20. Insight Into the Infectious Diseases Associated With Celiac Disease: A Guild to Novel Approaches for Diagnosis and Treatment, Govaresh (2023)

Style	Citing Format
MLA	Gholammostafaei FS, et al.. "Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review." Gastroenterology and Hepatology from Bed to Bench, vol. 14, no. , 2021, pp. S24-S31.
APA	Gholammostafaei FS, Didari T, Ramandi M, Vafaee R, Rostaminejad M (2021). Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review. Gastroenterology and Hepatology from Bed to Bench, 14(), S24-S31.
Chicago	Gholammostafaei FS, Didari T, Ramandi M, Vafaee R, Rostaminejad M. "Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review." Gastroenterology and Hepatology from Bed to Bench 14, no. (2021): S24-S31.
Harvard	Gholammostafaei FS et al. (2021) 'Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review', Gastroenterology and Hepatology from Bed to Bench, 14(), pp. S24-S31.
Vancouver	Gholammostafaei FS, Didari T, Ramandi M, Vafaee R, Rostaminejad M. Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review. Gastroenterology and Hepatology from Bed to Bench. 2021;14():S24-S31.
BibTex	@article{ author = {Gholammostafaei FS and Didari T and Ramandi M and Vafaee R and Rostaminejad M}, title = {Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review}, journal = {Gastroenterology and Hepatology from Bed to Bench}, volume = {14}, number = {}, pages = {S24-S31}, year = {2021} }
RIS	TY - JOUR AU - Gholammostafaei FS AU - Didari T AU - Ramandi M AU - Vafaee R AU - Rostaminejad M TI - Gut Microbiota, Angiotensin-Converting Enzyme, Celiac Disease, and Risk of Covid-19 Infection: A Review JO - Gastroenterology and Hepatology from Bed to Bench VL - 14 IS - SP - S24 EP - S31 PY - 2021 ER -

Science Communicator Platform

Authors

Abstract